Related Experiment Video
Updated: Aug 4, 2025

08:20
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
Published on: October 27, 2023
1.5K
Smart Artificial Intelligence techniques using embedded band for diagnosis and combating COVID-19.
M Ashwin1, Abdulrahman Saad Alqahtani2, Azath Mubarakali3
1Department of Artificial Intelligence and Data Science, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Andhra Pradesh, India.
Summary
Artificial Intelligence (AI) aids in combating COVID-19 by analyzing lung images. Deep learning models like Recurrent Neural Network (RNN) and Convolutional Neural Network (CNN) rapidly diagnose infections, offering crucial support in managing the pandemic.
Area of Science:
- Medical Imaging
- Artificial Intelligence
- Epidemiology
Background:
- The SARS-CoV-2 virus caused a global COVID-19 pandemic starting in December 2019.
- The World Health Organization declared COVID-19 a worldwide epidemic on March 11, 2020.
- Lung infections are a primary concern in COVID-19 patients.
Purpose of the Study:
- To detect the spread of the COVID-19 virus.
- To rapidly address lung infections caused by the virus.
- To explore Artificial Intelligence (AI) as a tool against the COVID-19 epidemic.
Main Methods:
- Utilized AI and computational techniques for COVID-19 analysis.
- Employed Deep Learning methods, specifically Recurrent Neural Network (RNN) and Convolutional Neural Network (CNN).
- Applied RNN and CNN to classify and identify regions affected by COVID-19 in lung images.
Main Results:
- AI techniques, including RNN and CNN, demonstrated potential in diagnosing COVID-19 infections.
- The study highlights AI's role in medical imaging for diagnosis and lung delineation.
- AI applications extend to lesion measurement, disease tracking, and patient outcome prediction.
Conclusions:
- AI, particularly Deep Learning models like RNN and CNN, offers a rapid diagnostic approach for COVID-19.
- AI applications are vital for various aspects of managing the COVID-19 pandemic, from diagnosis to drug development and epidemiology.

